Status:
COMPLETED
Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
HPV
Cervical Cancer
Eligibility:
FEMALE
16-23 years
Phase:
PHASE2
Brief Summary
This dose-ranging study is to evaluate an investigational vaccine with the following objectives: (1) To demonstrate that the vaccine is well-tolerated in women (2) To evaluate immune responses in wome...
Eligibility Criteria
Inclusion
- Lifetime history of 0-4 sexual partners
Exclusion
- History of abnormal PAP test or abnormal cervical biopsy result; history of external genital/vaginal warts; history of positive HPV test
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
680 Patients enrolled
Trial Details
Trial ID
NCT00260039
Start Date
December 1 2005
End Date
August 1 2007
Last Update
June 8 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.